• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on an article: "Coagulopathy in COVID-19".

作者信息

Ibrahimagić Omer Ć, Smajlović Dževdet, Dostović Zikrija, Kunić Suljo, Šehanović Aida, Kojić Biljana

机构信息

Department of Neurology, University Cinical Centre Tuzla, Tuzla, Bosnia and Herzegovina.

Department of Neurology, Primary Health Care Centre Tuzla, Tuzla, Bosnia and Herzegovina.

出版信息

J Thromb Haemost. 2020 Dec;18(12):3381-3382. doi: 10.1111/jth.15122.

DOI:10.1111/jth.15122
PMID:33090645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7675698/
Abstract
摘要

相似文献

1
Comment on an article: "Coagulopathy in COVID-19".对一篇文章《新型冠状病毒肺炎中的凝血病》的评论
J Thromb Haemost. 2020 Dec;18(12):3381-3382. doi: 10.1111/jth.15122.
2
COVID-19, coagulopathy and venous thromboembolism: more questions than answers-comment.新型冠状病毒肺炎、凝血病与静脉血栓栓塞症：问题多于答案——评论
Intern Emerg Med. 2021 Mar;16(2):525-526. doi: 10.1007/s11739-020-02503-z. Epub 2020 Sep 17.
3
COVID-19 coagulopathy: is it disseminated intravascular coagulation?COVID-19 凝血功能障碍：是弥散性血管内凝血吗？
Intern Emerg Med. 2021 Mar;16(2):309-312. doi: 10.1007/s11739-020-02601-y. Epub 2020 Dec 24.
4
Reply to: COVID-19 and Coagulopathy.回复：新型冠状病毒肺炎与凝血病
Am J Respir Cell Mol Biol. 2021 Jun;64(6):764-766. doi: 10.1165/rcmb.2021-0103LE.
5
[Dealing with COVID-19-associated coagulopathy].[应对新型冠状病毒肺炎相关凝血病]
Ned Tijdschr Geneeskd. 2020 Apr 15;164:D5031.
6
Thromboplasminflammation in COVID-19 Coagulopathy: Three Viewpoints for Diagnostic and Therapeutic Strategies.新型冠状病毒病凝血障碍中的血栓调节蛋白炎症：诊断和治疗策略的三个观点。
Front Immunol. 2021 Jun 11;12:649122. doi: 10.3389/fimmu.2021.649122. eCollection 2021.
7
Warning on coagulopathy COVID-19 related in microsurgical procedures.关于显微外科手术中与COVID-19相关的凝血病的警告。
Microsurgery. 2021 Jul;41(5):503-504. doi: 10.1002/micr.30744. Epub 2021 Apr 14.
8
COVID-19 and Coagulopathy.新型冠状病毒肺炎与凝血病
Am J Respir Cell Mol Biol. 2021 Jun;64(6):764. doi: 10.1165/rcmb.2020-0588LE.
9
Complement activation and coagulopathy - an ominous duo in COVID19.补体激活与凝血障碍——COVID-19 中的凶险组合。
Expert Rev Hematol. 2021 Feb;14(2):155-173. doi: 10.1080/17474086.2021.1875813. Epub 2021 Jan 22.
10
Defibrotide in the COVID-19 coagulopathy: What is the timing?去纤苷治疗新型冠状病毒肺炎凝血病：时机如何？
J Thromb Haemost. 2020 Nov;18(11):3113-3115. doi: 10.1111/jth.15100.

引用本文的文献

1
Gut microbiome alterations in patients with COVID-19-related coagulopathy.新型冠状病毒相关凝血功能障碍患者的肠道微生物组改变。
Ann Hematol. 2023 Jun;102(6):1589-1598. doi: 10.1007/s00277-023-05186-6. Epub 2023 Apr 11.

本文引用的文献

1
Coagulopathy in COVID-19.新型冠状病毒疾病中的凝血功能障碍。
J Thromb Haemost. 2020 Sep;18(9):2103-2109. doi: 10.1111/jth.14975. Epub 2020 Jul 21.
2
Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients.COVID-19 相关急性肺栓塞：7 例患者初步报告。
Int J Cardiol. 2020 Aug 15;313:129-131. doi: 10.1016/j.ijcard.2020.04.028. Epub 2020 May 26.
3
Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19.同型半胱氨酸作为新冠病毒肺炎患者心血管风险的潜在预测指标
Med Hypotheses. 2020 Oct;143:109859. doi: 10.1016/j.mehy.2020.109859. Epub 2020 May 21.
4
Medications in COVID-19 patients: summarizing the current literature from an orthopaedic perspective.COVID-19 患者的药物治疗：从骨科角度总结当前文献。
Int Orthop. 2020 Aug;44(8):1599-1603. doi: 10.1007/s00264-020-04643-5. Epub 2020 May 22.
5
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence.2019冠状病毒病患者的肺栓塞：对患病率增加的认识
Circulation. 2020 Jul 14;142(2):184-186. doi: 10.1161/CIRCULATIONAHA.120.047430. Epub 2020 Apr 24.
6
Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients.2019冠状病毒病（COVID-19）患者胸部CT影像进展的预测因素
Aging (Albany NY). 2020 Apr 10;12(7):6037-6048. doi: 10.18632/aging.102999.
7
Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor.在接受替格瑞洛治疗的冠心病患者中同型半胱氨酸水平与血小板反应性。
Nutr Metab Cardiovasc Dis. 2020 Feb 10;30(2):292-299. doi: 10.1016/j.numecd.2019.09.018. Epub 2019 Sep 30.
8
Polymorphisms C677T and A1298C of MTHFR Gene: Homocysteine Levels and Prothrombotic Biomarkers in Coronary and Pulmonary Thromboembolic Disease.亚甲基四氢叶酸还原酶基因 C677T 和 A1298C 多态性：冠状动脉和肺血栓栓塞性疾病中的同型半胱氨酸水平和促血栓生物标志物。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029618780344. doi: 10.1177/1076029618780344. Epub 2018 Jun 19.
9
HYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON'S DISEASE.帕金森病患者的高同型半胱氨酸血症及其治疗
Mater Sociomed. 2016 Jul 24;28(4):303-306. doi: 10.5455/msm.2016.28.303-306.
10
Hyperhomocysteinemia in movement disorders: Current evidence and hypotheses.运动障碍中的高同型半胱氨酸血症：当前证据与假说
Curr Vasc Pharmacol. 2006 Jul;4(3):237-43. doi: 10.2174/157016106777698414.